Collaborative protocol design is essential in the development of autologous cell therapy clinical trials, as it ensures comprehensive input from diverse stakeholders, reduces protocol amendments, and helps avoid clinical holds. By leveraging expertise from multiple departments and key opinion leaders, sponsors can create protocols that are both feasible and aligned with regulatory expectations. For a deeper dive into the significance of collaboration in protocol design, check out the full article.
